Insmed Inc. buy Guggenheim
Start price
05.09.23
/
50%
€24.60
Target price
05.09.24
€48.49
Performance (%)
164.23%
End price
06.09.24
€65.00
Summary
This prediction ended on 06.09.24 with a price of €65.00. With a performance of 164.23% the BUY prediction by Guggenheim was a big success. Guggenheim has a follow-up prediction for Insmed Inc. where he still thinks Insmed Inc. is a Buy. Guggenheim has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Insmed Inc. | 24.003% | 24.003% | -3.018% |
| iShares Core DAX® | 0.437% | 5.897% | 8.047% |
| iShares Nasdaq 100 | 1.057% | 0.920% | 28.466% |
| iShares Nikkei 225® | 1.769% | 1.228% | 47.574% |
| iShares S&P 500 | 0.368% | 1.920% | 23.200% |
Comments by Guggenheim for this prediction
In the thread Insmed Inc. diskutieren
Insmed Incorporated (NASDAQ: INSM) had its price target raised by analysts at Guggenheim from $50.00 to $52.00. They now have a "buy" rating on the stock.
Ratings data for INSM provided by MarketBeat
In the thread Trading Insmed Inc.
Die von Guggenheim gewählte maximale Laufzeit wurde überschritten